InBody Co (041830.KQ) Stock Price

InBody Co Price

KRX·CLOSED
47,500.00KRW-900.00 (-1.88 %)
Market closed

Over the last 19 years InBody Co grew revenue by 16.9% annually, reaching 233.95 B KRW. Earnings per share have grown at 42.4% per year over the last 12 years. For InBody Co, the net margin of 13.1% is down versus 24.7% a few years ago. At today's price the dividend yield works out to roughly 0.84%. The payout ratio is around 8% of earnings. The dividend has grown at 12.2% per year over the past 18 years. The consensus 12-month price target for InBody Co is 37,740.00 KRW, about 20.5% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 102% above its 52-week low.

InBody Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of InBody Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how InBody Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing InBody Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

InBody Co Stock Price History
DateInBody Co Price
7/24/202647,500.00 KRW
7/23/202648,400.00 KRW
7/22/202649,700.00 KRW
7/21/202653,400.00 KRW
7/20/202650,600.00 KRW
7/16/202654,200.00 KRW
7/15/202655,500.00 KRW
7/14/202651,100.00 KRW
7/13/202651,700.00 KRW
7/10/202652,500.00 KRW
7/9/202655,500.00 KRW
7/8/202654,300.00 KRW
7/7/202656,000.00 KRW
7/6/202658,200.00 KRW
7/3/202655,300.00 KRW
7/2/202658,600.00 KRW
7/1/202662,000.00 KRW
6/30/202658,000.00 KRW
6/29/202650,400.00 KRW
6/26/202645,100.00 KRW
6/25/202646,950.00 KRW
6/24/202645,450.00 KRW
6/23/202644,450.00 KRW
6/22/202646,350.00 KRW
6/19/202646,450.00 KRW
6/18/202646,400.00 KRW
6/17/202646,700.00 KRW
6/16/202645,500.00 KRW
6/15/202645,550.00 KRW
6/12/202644,350.00 KRW
6/11/202646,200.00 KRW
6/10/202645,650.00 KRW
6/9/202641,350.00 KRW
6/8/202637,650.00 KRW
6/5/202639,800.00 KRW
6/4/202642,450.00 KRW
6/2/202642,750.00 KRW
6/1/202642,750.00 KRW
5/29/202645,850.00 KRW
5/28/202646,800.00 KRW
5/27/202646,400.00 KRW
5/26/202646,000.00 KRW
5/22/202647,350.00 KRW
5/21/202642,350.00 KRW
5/20/202643,350.00 KRW
5/19/202644,300.00 KRW
5/18/202644,300.00 KRW
5/15/202644,800.00 KRW
5/14/202646,050.00 KRW
5/13/202645,000.00 KRW
5/12/202644,400.00 KRW
5/11/202645,400.00 KRW
5/8/202638,500.00 KRW
5/7/202629,650.00 KRW
5/6/202630,000.00 KRW
5/4/202629,650.00 KRW
4/30/202629,500.00 KRW
4/29/202630,250.00 KRW
4/28/202629,700.00 KRW
4/27/202630,050.00 KRW
4/24/202630,500.00 KRW
4/23/202629,350.00 KRW
4/22/202629,500.00 KRW
4/21/202629,100.00 KRW
4/20/202629,650.00 KRW
4/17/202629,450.00 KRW
4/16/202629,550.00 KRW
4/15/202629,900.00 KRW
4/14/202629,300.00 KRW
4/13/202629,350.00 KRW
4/10/202629,700.00 KRW
4/9/202628,850.00 KRW
4/8/202628,300.00 KRW
4/7/202627,400.00 KRW
4/6/202627,900.00 KRW
4/3/202628,350.00 KRW
4/2/202628,400.00 KRW
4/1/202629,500.00 KRW
3/31/202627,600.00 KRW
3/30/202628,400.00 KRW
3/27/202628,900.00 KRW
3/26/202629,750.00 KRW
3/25/202630,000.00 KRW
3/24/202628,750.00 KRW
3/23/202628,200.00 KRW
3/20/202629,700.00 KRW
3/19/202628,650.00 KRW
3/18/202629,400.00 KRW
3/17/202629,250.00 KRW
3/16/202630,200.00 KRW
3/13/202629,600.00 KRW
3/12/202629,600.00 KRW
3/11/202630,250.00 KRW
3/10/202629,700.00 KRW
3/9/202628,550.00 KRW
3/6/202628,900.00 KRW
3/5/202629,600.00 KRW
3/4/202628,650.00 KRW
3/3/202631,600.00 KRW
2/27/202632,000.00 KRW
2/26/202633,500.00 KRW
2/25/202634,500.00 KRW
2/24/202634,650.00 KRW
2/23/202635,600.00 KRW
2/20/202634,400.00 KRW
2/19/202635,050.00 KRW
2/13/202634,250.00 KRW
2/12/202634,800.00 KRW
2/11/202634,750.00 KRW
2/10/202635,350.00 KRW
2/9/202634,700.00 KRW
2/6/202633,500.00 KRW
2/5/202634,350.00 KRW
2/4/202633,250.00 KRW
2/3/202632,600.00 KRW
2/2/202631,750.00 KRW
1/30/202632,650.00 KRW
1/29/202632,500.00 KRW
1/28/202631,400.00 KRW
1/27/202631,150.00 KRW
1/26/202631,250.00 KRW
1/23/202630,300.00 KRW
1/22/202629,550.00 KRW
1/21/202629,500.00 KRW
1/20/202630,300.00 KRW
1/19/202630,100.00 KRW
1/16/202630,400.00 KRW
1/15/202629,600.00 KRW
1/14/202630,150.00 KRW
1/13/202630,250.00 KRW
1/12/202630,450.00 KRW
1/9/202630,550.00 KRW
1/8/202631,500.00 KRW
1/7/202632,500.00 KRW
1/6/202632,450.00 KRW
1/5/202632,800.00 KRW
1/2/202632,650.00 KRW
12/30/202532,750.00 KRW
12/29/202532,500.00 KRW
12/26/202531,750.00 KRW
12/24/202533,050.00 KRW
12/23/202532,350.00 KRW
12/22/202532,650.00 KRW
12/19/202531,900.00 KRW
12/18/202531,600.00 KRW
12/17/202532,000.00 KRW
12/16/202532,400.00 KRW
12/15/202532,850.00 KRW
12/12/202533,900.00 KRW
12/11/202533,750.00 KRW
12/10/202531,550.00 KRW
12/9/202531,850.00 KRW
12/8/202529,700.00 KRW
12/5/202529,900.00 KRW
12/4/202529,700.00 KRW
12/3/202530,750.00 KRW
12/2/202531,150.00 KRW
12/1/202531,200.00 KRW
11/28/202531,150.00 KRW
11/27/202529,000.00 KRW
11/26/202528,750.00 KRW
11/25/202528,100.00 KRW
11/24/202528,300.00 KRW
11/21/202528,400.00 KRW
11/20/202528,000.00 KRW
11/19/202527,600.00 KRW
11/18/202528,650.00 KRW
11/17/202529,050.00 KRW
11/14/202529,200.00 KRW
11/13/202529,750.00 KRW
11/12/202530,250.00 KRW
11/11/202528,750.00 KRW
11/10/202528,500.00 KRW
11/7/202527,300.00 KRW
11/6/202527,150.00 KRW
11/5/202527,050.00 KRW
11/4/202526,950.00 KRW
11/3/202527,750.00 KRW
10/31/202528,650.00 KRW
10/30/202526,950.00 KRW
10/29/202529,150.00 KRW
10/28/202529,350.00 KRW
10/27/202528,450.00 KRW
10/24/202528,650.00 KRW
10/23/202527,550.00 KRW
10/22/202528,400.00 KRW
10/21/202527,700.00 KRW
10/20/202528,100.00 KRW
10/17/202528,350.00 KRW
10/16/202528,850.00 KRW
10/15/202529,850.00 KRW
10/14/202530,000.00 KRW
10/13/202531,050.00 KRW
10/10/202531,600.00 KRW
10/2/202531,750.00 KRW
10/1/202529,400.00 KRW
9/30/202529,250.00 KRW
9/29/202529,400.00 KRW
9/26/202527,850.00 KRW
9/25/202528,350.00 KRW
9/24/202529,300.00 KRW
9/23/202529,050.00 KRW
9/22/202528,100.00 KRW
9/19/202528,700.00 KRW
9/18/202528,750.00 KRW
9/17/202528,700.00 KRW
9/16/202527,700.00 KRW
9/15/202527,500.00 KRW
9/12/202527,700.00 KRW
9/11/202527,550.00 KRW
9/10/202526,650.00 KRW
9/9/202526,550.00 KRW
9/8/202527,150.00 KRW
9/5/202527,050.00 KRW
9/4/202527,350.00 KRW
9/3/202527,100.00 KRW
9/2/202526,650.00 KRW
9/1/202526,550.00 KRW
8/29/202527,100.00 KRW
8/28/202528,450.00 KRW
8/27/202528,250.00 KRW
8/26/202527,550.00 KRW
8/25/202527,700.00 KRW
8/22/202527,950.00 KRW
8/21/202528,400.00 KRW
8/20/202528,950.00 KRW
8/19/202529,450.00 KRW
8/18/202528,750.00 KRW
8/14/202528,250.00 KRW
8/13/202528,000.00 KRW
8/12/202528,050.00 KRW
8/11/202528,250.00 KRW
8/8/202528,500.00 KRW
8/7/202528,350.00 KRW
8/6/202528,300.00 KRW
8/5/202526,950.00 KRW
8/4/202525,050.00 KRW
8/1/202523,800.00 KRW
7/31/202523,800.00 KRW
7/30/202523,700.00 KRW
7/29/202523,850.00 KRW
7/28/202523,550.00 KRW
Access this data via the Eulerpool API
Get Free API Key

InBody Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
107.12 B KRW
19.10 B KRW
17.52 B KRW
Jan 1, 2021
137.84 B KRW
35.85 B KRW
34.03 B KRW
Jan 1, 2022
160.00 B KRW
40.70 B KRW
33.82 B KRW
Jan 1, 2023
170.35 B KRW
38.35 B KRW
36.72 B KRW
Jan 1, 2024
204.46 B KRW
36.74 B KRW
33.14 B KRW
Jan 1, 2025
233.95 B KRW
36.75 B KRW
30.63 B KRW
Jan 1, 2026 (e)
277.60 B KRW
45.45 B KRW
45.44 B KRW
Jan 1, 2027 (e)
329.40 B KRW
52.52 B KRW
51.61 B KRW

InBody Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 26, 2026, 5:49 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
201220132014201520162017201820192020202120222023202420252026e2027e
33.2336.7948.9468.9579.8593.2599.64117.06107.12137.84160.00170.35204.47233.95277.60329.40
5.2910.7033.0440.8815.8116.796.8417.49-8.4928.6716.086.4720.0314.4218.6618.66
544.72492.0669.8171.6972.4374.4973.2073.6972.3073.5175.6777.7577.3977.3777.3777.37
181.01181.0134.1749.4357.8469.4672.9386.2677.45101.32121.07132.46158.23181.01214.78254.86
5.006.5010.1020.0121.8524.9023.6827.4319.1035.8540.7038.3536.7436.7545.4552.52
15.0517.6720.6329.0227.3626.7023.7623.4317.8326.0125.4322.5117.9715.7116.3715.94
5.646.198.8817.3116.9919.3219.6720.4317.5234.0333.8236.7233.1430.6345.4451.61
1.959.7843.3594.95-1.8713.751.813.85-14.2594.27-0.648.60-9.75-7.5748.3513.58
40.0040.0060.0080.00100.00120.00120.00140.00140.00200.00300.00350.00350.00400.00480.00576.00
––50.0033.3325.0020.00–16.67–42.8650.0016.67–14.2920.0020.00
13.4713.4713.4713.4713.4713.4913.4713.4713.4713.4713.4713.4713.4713.4713.4713.47
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales InBody Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue InBody Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare InBody Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares InBody Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against InBody Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

InBody Co stock margins

The InBody Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of InBody Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for InBody Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
72.30 %
17.83 %
16.35 %
Jan 1, 2021
73.51 %
26.01 %
24.69 %
Jan 1, 2022
75.67 %
25.44 %
21.13 %
Jan 1, 2023
77.75 %
22.51 %
21.56 %
Jan 1, 2024
77.39 %
17.97 %
16.21 %
Jan 1, 2025
77.37 %
15.71 %
13.09 %
Jan 1, 2026 (e)
77.37 %
16.37 %
16.37 %
Jan 1, 2027 (e)
77.37 %
15.94 %
15.67 %

InBody Co Stock Revenue, EBIT, Earnings per Share

The InBody Co earnings per share therefore indicates how much revenue InBody Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2021
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2022
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2023
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2024
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2025
0.00 KRW
0.00 KRW
0.00 KRW
Jan 1, 2026 (e)
21,417.11 KRW
3,374.09 KRW
3,506.00 KRW
Jan 1, 2027 (e)
25,413.53 KRW
3,898.95 KRW
3,982.00 KRW

InBody Co business model & stock analysis

InBody Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

InBody Co historical P/E ratio, EBIT multiple, and P/S ratio

InBody Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

InBody Co shares outstanding

The number of shares of InBody Co was 13.47 M in 2025. This indicates how many shares InBody Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
13.47 M Stocks
Jan 1, 2021
13.47 M Stocks
Jan 1, 2022
13.47 M Stocks
Jan 1, 2023
13.47 M Stocks
Jan 1, 2024
13.47 M Stocks
Jan 1, 2025
13.47 M Stocks
Jan 1, 2026 (e)
13.47 M Stocks
Jan 1, 2027 (e)
13.47 M Stocks

InBody Co stock splits

In InBody Co's history, there have been no stock splits.

InBody Co Dividend History

24 years of dividend payments

YearAnnual DividendYoY ChangePayments
2025400.00KRW↑ 14.3%1×
Mar 28, 2025400.00KRW↑ 14.3%1/1
2024350.00KRW 0.0%—
2023350.00KRW↑ 16.7%1×
2022300.00KRW↑ 50.0%1×
2021200.00KRW↑ 42.9%1×
2020140.00KRW 0.0%1×
2019140.00KRW↑ 16.7%1×
2018120.00KRW 0.0%1×
2017120.00KRW↑ 20.0%1×
2016100.00KRW↑ 25.0%1×

InBody Co dividend history and estimates

In 2025, InBody Co paid a dividend amounting to 400.00 KRW. Dividend means that InBody Co distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
140.00 KRW
0.00 KRW
Jan 1, 2021
200.00 KRW
0.00 KRW
Jan 1, 2022
300.00 KRW
0.00 KRW
Jan 1, 2023
350.00 KRW
0.00 KRW
Jan 1, 2024
350.00 KRW
0.00 KRW
Jan 1, 2025
400.00 KRW
0.00 KRW
Jan 1, 2026 (e)
0.00 KRW
480.00 KRW
Jan 1, 2027 (e)
0.00 KRW
576.00 KRW

InBody Co dividend payout ratio

In 2025, InBody Co had a payout ratio of 8.29%. The payout ratio indicates the percentage of the company's profits that InBody Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
8.30 %
Jan 1, 2021
8.27 %
Jan 1, 2022
8.29 %
Jan 1, 2023
8.29 %
Jan 1, 2024
8.28 %
Jan 1, 2025
8.29 %
Jan 1, 2026 (e)
13.69 %
Jan 1, 2027 (e)
14.47 %

Current InBody Co forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy80.00 % (4)
Hold20.00 % (1)
Sell0.00 % (0)
12M Price Target
37,740.00
Last Price
47,500.00
Currency
KRW
12M Return Potential
-20.55 %
LTM Return
0 %

InBody Co shareholder structure

% Name
18.86341%
Cha (Gi Cheol)
Cha (Gi Cheol)
10.54661%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
10.18393%
Cha (In Jun)
Cha (In Jun)
6.54027%
FIL Investment Management (Hong Kong) Limited
FIL Investment Management (Hong Kong) Limited
2.14517%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.98411%
Fidelity Institutional Asset Management
Fidelity Institutional Asset Management

InBody Co Executives and Management Board

GC

Gi Cheol Cha

(66)

Chairman, Chief Executive Officer · since 2024

GY

Gyeong Ho Yoo

(35)

Vice President, Director · since 2010

TK

Taek Seon Kim

(56)

Internal Auditor · since 2008

JL

Jae Tak Lee

IR Contact Officer

Frequently asked questions about InBody Co

Analysts currently set an average price target of 37,740.00 KRW for the InBody Co stock (median: 37,740.00 KRW), implying -20.5 % versus the latest price. The consensus is based on 5 analyst ratings.

InBody Co Analyst Price Targets 2026

All fundamentals and in-depth analysis of InBody Co

Our stock analysis for InBody Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of InBody Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

InBody Co Stock
InBody Co Revenue→
InBody Co Stock
InBody Co Net Income→
InBody Co Stock
InBody Co P/E→
InBody Co Stock
InBody Co P/S→
InBody Co Stock
InBody Co EBIT→
InBody Co Stock
InBody Co Dividend→
InBody Co Stock
InBody Co Directors Dealings→
InBody Co Stock
InBody Co Stocks→
InBody Co Stock
InBody Co Market capitalization→
InBody Co Stock
InBody Co Debt→
InBody Co Stock
InBody Co Liabilities→
InBody Co Stock
InBody Co Equity→
InBody Co Stock
InBody Co AAQS→
InBody Co Stock
InBody Co Employees→
InBody Co Stock
InBody Co ROE→
InBody Co Stock
InBody Co ROA→
InBody Co Stock
InBody Co ROCE→
InBody Co Stock
InBody Co News→
InBody Co Stock
InBody Co Analyst Price Targets→

Health Stocks

Incannex HealthcareIN8bioIncyteIMVIND Swift LaboratoriesImunonIndaptus TherapeuticsImugeneIndivior PharmaceuticalsImprove Medical Instruments CoIndoco RemediesImplanetAll Stocks A–Z →